1,2,3,4-tetrahydroisoquinoline has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, FI; Decker, AM; Fennell, TR; Kormos, CM; Mascarella, SW; Navarro, HA; Ondachi, PW; Runyon, SP; Snyder, RW; Thomas, JB | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and guanosine 5'-o-(3-thiotriphosphate)
| Article | Year |
|---|---|
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic).
Topics: Animals; Brain; CHO Cells; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Narcotic Antagonists; Radioligand Assay; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Tetrahydroisoquinolines | 2018 |